340B providers leverage spread pricing to generate revenue, creating unintended consequences in the broader healthcare market. This white paper addresses potential opportunities to restructure program benefits. The post Cui Bono? Misaligned Incentives in the 340B Program appeared first on USC Schaeffer.
